Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Michael Munchhof Clear advanced filters
  • Here it is shown that Hedgehog signalling is important in chronic myeloid leukaemia (CML), where it acts to maintain leukaemia stem cells by regulating the expression of Numb. CML stem cells can be depleted when Hedgehog signalling is inhibited, including cells that are resistant to the drug imatinib that is used to treat CML.

    • Chen Zhao
    • Alan Chen
    • Tannishtha Reya
    Research
    Nature
    Volume: 458, P: 776-779
  • The primary goal of a process chemist is to develop a commercially viable synthetic route to a known drug candidate. The approaches to a synthetic challenge are consequently very different to those used in medicinal chemistry. This Review uses case studies to highlight important considerations, and the tactics used during the design and selection of an efficient drug synthesis.

    • Martin D. Eastgate
    • Michael A. Schmidt
    • Keith R. Fandrick
    Reviews
    Nature Reviews Chemistry
    Volume: 1, P: 1-16
  • Protein methyltransferase PRMT5 symmetrically dimethylates arginine residues in proteins, including histones, and has been associated with tumorigenesis. The identification of EPZ015666 as a potent chemical probe of PRMT5 could promote understanding of the role of PRMT5 in human disease both in cells and in vivo.

    • Elayne Chan-Penebre
    • Kristy G Kuplast
    • Kenneth W Duncan
    Research
    Nature Chemical Biology
    Volume: 11, P: 432-437